Literature DB >> 29168320

Pulmonary hypertension in the premature infant population: Analysis of echocardiographic findings and biomarkers.

Michael G O'Connor1, Divya Suthar2, Kimberly Vera2, James C Slaughter3, Natalie L Maitre4, Steven Steele5, Amy Beller5, Candice D Fike6, Judy L Aschner7, Paul E Moore1, Eric D Austin1.   

Abstract

OBJECTIVE: Extremely low gestational age neonates (ELGANs) are at risk for pulmonary hypertension (PH). We hypothesized that PH, defined by echocardiogram at 36 weeks gestational age (GA), would associate with respiratory morbidity, increased oxidant stress, and reduced nitric oxide production. STUDY
DESIGN: ELGANs in the Vanderbilt fraction of the Prematurity and Respiratory Outcomes Program (PROP) who had echocardiograms at 36 ± 1 weeks GA were studied. Echocardiogram features of PH were compared with clinical characteristics as well as markers of oxidant stress and components of the nitric oxide pathway. Biomarkers were obtained at enrollment (median day 3), 7, 14, and 28 days of life.
RESULTS: Sixty of 172 infants had an echocardiogram at 36 weeks; 11 had evidence of PH. Infants did not differ by PH status in regards to demographics, respiratory morbidity, or oxidant stress. However, odds of more severe PH were significantly higher in infants with higher nitric oxide metabolites (NOx) at enrollment and with a lower citrulline level at day 7.
CONCLUSIONS: Respiratory morbidity may not always associate with PH at 36 weeks among ELGANs. However, components of nitric oxide metabolism are potential biologic markers of PH in need of further study.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarkers; bronchopulmonary dysplasia; pulmonary hypertension

Mesh:

Substances:

Year:  2017        PMID: 29168320      PMCID: PMC5815883          DOI: 10.1002/ppul.23913

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  29 in total

Review 1.  Echocardiographic assessment of pulmonary hypertension in infants with bronchopulmonary dysplasia: systematic review of literature and a proposed algorithm for assessment.

Authors:  Mohamed Nagiub; Sam Lee; Lokesh Guglani
Journal:  Echocardiography       Date:  2014-09-18       Impact factor: 1.724

2.  Clinical features of paediatric pulmonary hypertension: a registry study.

Authors:  Rolf M F Berger; Maurice Beghetti; Tilman Humpl; Gary E Raskob; D Dunbar Ivy; Zhi-Cheng Jing; Damien Bonnet; Ingram Schulze-Neick; Robyn J Barst
Journal:  Lancet       Date:  2012-01-11       Impact factor: 79.321

3.  Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program.

Authors:  Brenda B Poindexter; Rui Feng; Barbara Schmidt; Judy L Aschner; Roberta A Ballard; Aaron Hamvas; Anne Marie Reynolds; Pamela A Shaw; Alan H Jobe
Journal:  Ann Am Thorac Soc       Date:  2015-12

Review 4.  The toxicology of inhaled nitric oxide.

Authors:  B Weinberger; D L Laskin; D E Heck; J D Laskin
Journal:  Toxicol Sci       Date:  2001-01       Impact factor: 4.849

5.  Oxygen requirement as a screening tool for the detection of late pulmonary hypertension in extremely low birth weight infants.

Authors:  Rohit Aswani; Lisa Hayman; Gina Nichols; Angel A Luciano; Ernest K Amankwah; Jennifer L Leshko; Gul H Dadlani
Journal:  Cardiol Young       Date:  2015-06-29       Impact factor: 1.093

6.  Inhaled nitric oxide increases urinary nitric oxide metabolites and cyclic guanosine monophosphate in premature infants: relationship to pulmonary outcome.

Authors:  Philip L Ballard; Roberta L Keller; Dennis M Black; David J Durand; Jeffrey D Merrill; Eric C Eichenwald; William E Truog; Mark C Mammel; Robin Steinhorn; Rita M Ryan; Sherry E Courtney; Hart Horneman; Roberta A Ballard
Journal:  Am J Perinatol       Date:  2014-06-26       Impact factor: 1.862

Review 7.  Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia.

Authors:  Peter M Mourani; Steven H Abman
Journal:  Clin Perinatol       Date:  2015-09-26       Impact factor: 3.430

Review 8.  The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells.

Authors:  Larry P Solomonson; Brenda R Flam; Laura C Pendleton; Bonnie L Goodwin; Duane C Eichler
Journal:  J Exp Biol       Date:  2003-06       Impact factor: 3.312

Review 9.  Recent advances in the mechanisms of lung alveolarization and the pathogenesis of bronchopulmonary dysplasia.

Authors:  Diogo M G Silva; Claudio Nardiello; Agnieszka Pozarska; Rory E Morty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-11       Impact factor: 5.464

10.  Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; D Dunbar Ivy; Steven H Abman
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

View more
  2 in total

1.  Using clinical and genetic data to predict pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  J K Trittmann; A Bartenschlag; E J Zmuda; J Frick; W C L Stewart; L D Nelin
Journal:  Acta Paediatr       Date:  2018-12       Impact factor: 2.299

Review 2.  Bronchopulmonary dysplasia.

Authors:  Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe
Journal:  Nat Rev Dis Primers       Date:  2019-11-14       Impact factor: 52.329

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.